Immuneering Corp (IMRX)
1.98
+0.12
(+6.45%)
USD |
NASDAQ |
Nov 05, 16:00
1.98
0.00 (0.00%)
After-Hours: 18:47
Immuneering Enterprise Value: -4.573M for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | -4.573M |
| November 01, 2024 | -4.277M |
| October 31, 2024 | -4.573M |
| October 30, 2024 | -2.794M |
| October 29, 2024 | -1.015M |
| October 28, 2024 | 3.730M |
| October 25, 2024 | -0.1251M |
| October 24, 2024 | 4.026M |
| October 23, 2024 | 4.323M |
| October 22, 2024 | 5.509M |
| October 21, 2024 | 4.323M |
| October 18, 2024 | 6.695M |
| October 17, 2024 | 2.247M |
| October 16, 2024 | 6.102M |
| October 15, 2024 | 8.771M |
| October 14, 2024 | -0.4217M |
| October 11, 2024 | 5.212M |
| October 10, 2024 | 6.102M |
| October 09, 2024 | 5.212M |
| October 08, 2024 | 11.14M |
| October 07, 2024 | 12.92M |
| October 04, 2024 | 13.52M |
| October 03, 2024 | 10.55M |
| October 02, 2024 | 12.33M |
| October 01, 2024 | 9.067M |
| Date | Value |
|---|---|
| September 30, 2024 | 14.11M |
| September 27, 2024 | 19.15M |
| September 26, 2024 | 17.67M |
| September 25, 2024 | 27.45M |
| September 24, 2024 | 26.86M |
| September 23, 2024 | 25.38M |
| September 20, 2024 | 35.46M |
| September 19, 2024 | 12.03M |
| September 18, 2024 | 7.881M |
| September 17, 2024 | 22.71M |
| September 16, 2024 | 25.38M |
| September 13, 2024 | 0.1714M |
| September 12, 2024 | -17.32M |
| September 11, 2024 | -21.48M |
| September 10, 2024 | -24.29M |
| September 09, 2024 | -25.33M |
| September 06, 2024 | -24.74M |
| September 05, 2024 | -24.44M |
| September 04, 2024 | -22.66M |
| September 03, 2024 | -23.85M |
| August 30, 2024 | -26.81M |
| August 29, 2024 | -25.33M |
| August 28, 2024 | -26.22M |
| August 27, 2024 | -26.22M |
| August 26, 2024 | -25.03M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-35.13M
Minimum
May 25 2022
801.56M
Maximum
Sep 27 2021
134.81M
Average
83.23M
Median
Jan 17 2024
Enterprise Value Benchmarks
| Singular Genomics Systems Inc | -71.17M |
| Biomarin Pharmaceutical Inc | 12.24B |
| Integra Lifesciences Holdings Corp | 3.399B |
| Eton Pharmaceuticals Inc | 202.70M |
| Tenon Medical Inc | 3.026M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -14.08M |
| Total Expenses (Quarterly) | 14.91M |
| EPS Diluted (Quarterly) | -0.47 |
| Earnings Yield | -96.46% |
| Normalized Earnings Yield | -96.97 |